TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology

$141.51 sample

-2.37 (-1.65%) 1D

Market cap

$919.5B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-09

Alerts

8

Price$141.51 -4.79% 3M daily closessample

158.56141.51

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: General Counsel
Sep 23INSInsider buy: 10% owner
Sep 16INSInsider sell: Director
Sep 09SEC8-K filed: material event
Sep 04INSInsider sell: Director
Aug 27INSInsider buy: Chief Financial Officer
Aug 24INSInsider sell: Chief Financial Officer
Aug 19INSInsider sell: Chief Financial Officer

Sign up to see the real TRAX record →

Company facts

SEC EDGAR registration

Name: First Tracks Biotherapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in TRAX

sample

Insiders: 11 insider transactions over 90 days, net selling, $601.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 38 funds hold $15.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.9B +20.2% y/y

Q4 2024Q3 2026

Inventory$21.2B +13.0% y/y

Q4 2024Q3 2026

Accounts receivable$16.6B +17.1% y/y

Q4 2024Q3 2026

Total debt$44.8B +17.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $253.6B +11.6% 3M
Sample peer B: $578.2B +4.7% 3M
Sample peer C: $166.1B +16.1% 3M
Sample peer D: $748.4B +3.4% 3M
Sample peer E: $648.9B +0.8% 3M